SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-09-000397
Filing Date
2009-01-26
Accepted
2009-01-26 13:48:13
Documents
2
Period of Report
2009-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_30995.htm 8-K 12581
2 EX-4.1 exhibit1.htm EX-4.1 18555
  Complete submission text file 0001299933-09-000397.txt   32787
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 09545039
SIC: 2836 Biological Products, (No Diagnostic Substances)